Skip to main content

Susan Halabi CV

James B. Duke Distinguished Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2717, Durham, NC 27710
2424 Erwin Road 11th Floor, 11088 Hock Plaza, Durham, NC 27705
CV

Keywords


Precision Medicine Dust Construction Materials Personalized medicine Diagnostic Imaging Multiprotein Complexes Family relationships Arab countries Lasso Germany Chemotherapy Cohort Studies Clinical trials Alkaline Phosphatase ROC Curve Survival Rate Vascular Endothelial Growth Factors Lymphokines Ketoconazole Pregnancy Contraceptives, Oral Confidence Intervals Receptors, Progesterone Adenocarcinoma, Clear Cell Population Surveillance Disease Progression Alleles Proportional Hazards Models Hispanic Americans Translocation, Genetic African Americans DNA Primers Age Factors DNA, Neoplasm Molecular Sequence Data Selective Estrogen Receptor Modulators Ribosomal Protein S6 Kinases Tamoxifen Predictive Value of Tests Cancer Vaccines Outcome Assessment (Health Care) Retrospective Studies Survival Analysis Prospective Studies Carcinoma, Renal Cell Sample Size Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic United States Risk Assessment Carcinoma Factor Analysis, Statistical Treatment Failure Mining Logistic Models Decision Making Adenocarcinoma Aged, 80 and over Multivariate Analysis Kaplan-Meier Estimate Case-Control Studies Risk Factors Area Under Curve Probability Survival Gene Expression Endpoint Determination Neoplasms, Hormone-Dependent Genetic Predisposition to Disease Graft vs Host Disease Chemoprevention Ovarian Neoplasms Genotype DNA Damage Population Gels Models, Theoretical Sensitivity and Specificity Statistics as Topic Genes, Immunoglobulin DNA Repair Validation Studies as Topic Genetics, Medical Efficiency, Organizational Nomograms Mutation Models, Biological Drug Design Equipment Design Residence Characteristics Reproducibility of Results Registries HIV Infections Computer Simulation Data Interpretation, Statistical Prognosis Models, Statistical Disease-Free Survival Biomarkers, Pharmacological Research Design Chi-Square Distribution Tumor Markers, Biological Treatment Outcome Urologic Neoplasms Decision Support Techniques Odds Ratio Risk Biological Markers Breast Neoplasms